237 related articles for article (PubMed ID: 29669579)
1. Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
Strand F; Humphreys K; Holm J; Eriksson M; Törnberg S; Hall P; Azavedo E; Czene K
Breast Cancer Res; 2018 Apr; 20(1):31. PubMed ID: 29669579
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
3. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
[TBL] [Abstract][Full Text] [Related]
4. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
5. A comparison of five methods of measuring mammographic density: a case-control study.
Astley SM; Harkness EF; Sergeant JC; Warwick J; Stavrinos P; Warren R; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Brentnall AR; Cuzick J; Howell T; Evans DG
Breast Cancer Res; 2018 Feb; 20(1):10. PubMed ID: 29402289
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
7. Mammographic density and risk of breast cancer by tumor characteristics: a case-control study.
Krishnan K; Baglietto L; Stone J; McLean C; Southey MC; English DR; Giles GG; Hopper JL
BMC Cancer; 2017 Dec; 17(1):859. PubMed ID: 29246131
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer.
Strand F; Humphreys K; Eriksson M; Li J; Andersson TM; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Int J Cancer; 2017 Jan; 140(1):34-40. PubMed ID: 27615710
[TBL] [Abstract][Full Text] [Related]
9. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for breast cancer in a cohort of mammographic screening program: a nested case-control study within the FRiCaM study.
Bravi F; Decarli A; Russo AG
Cancer Med; 2018 May; 7(5):2145-2152. PubMed ID: 29654663
[TBL] [Abstract][Full Text] [Related]
11. PAM50 and Risk of Recurrence Scores for Interval Breast Cancers.
Puvanesarajah S; Nyante SJ; Kuzmiak CM; Chen M; Tse CK; Sun X; Allott EH; Kirk EL; Carey LA; Perou CM; Olshan AF; Henderson LM; Troester MA
Cancer Prev Res (Phila); 2018 Jun; 11(6):327-336. PubMed ID: 29622545
[TBL] [Abstract][Full Text] [Related]
12. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
13. Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study.
Krishnan K; Baglietto L; Apicella C; Stone J; Southey MC; English DR; Giles GG; Hopper JL
Breast Cancer Res; 2016 Jun; 18(1):63. PubMed ID: 27316945
[TBL] [Abstract][Full Text] [Related]
14. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
[TBL] [Abstract][Full Text] [Related]
15. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
[TBL] [Abstract][Full Text] [Related]
16. BMI and breast cancer prognosis benefit: mammography screening reveals differences between normal weight and overweight women.
Crispo A; Grimaldi M; D'Aiuto M; Rinaldo M; Capasso I; Amore A; D'Aiuto G; Giudice A; Ciliberto G; Montella M
Breast; 2015 Feb; 24(1):86-9. PubMed ID: 25466863
[TBL] [Abstract][Full Text] [Related]
17. Mammographic screening reduces risk of breast carcinoma recurrence.
Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
[TBL] [Abstract][Full Text] [Related]
18. Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study.
Strand F; Azavedo E; Hellgren R; Humphreys K; Eriksson M; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2019 Jan; 21(1):8. PubMed ID: 30670066
[TBL] [Abstract][Full Text] [Related]
19. Early life socioeconomic environment and mammographic breast density.
Tehranifar P; Cohn BA; Flom JD; Protacio A; Cirillo P; Lumey LH; Michels KB; Terry MB
BMC Cancer; 2017 Jan; 17(1):41. PubMed ID: 28068940
[TBL] [Abstract][Full Text] [Related]
20. Tumor characteristics and family history in relation to mammographic density and breast cancer: The French E3N cohort.
Maskarinec G; Dartois L; Delaloge S; Hopper J; Clavel-Chapelon F; Baglietto L
Cancer Epidemiol; 2017 Aug; 49():156-160. PubMed ID: 28697417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
